Fatigue can be a side effect for some individuals taking Semaglutide, though it is not experienced by everyone
Semaglutide also improves blood sugar control in several ways
Cao S, Pan Y, Tang J, Terker AS, Arroyo Ornelas JP, Jin G-N, Wang Y, Niu A, Fan X, Wang S
In a clinical study involving 1,651,452 patients with type 2 diabetes, semaglutide decreased the development of 10 out of 13 obesity-associated cancers, which include the following: Colorectal cancer Meningioma Endometrial cancer Gallbladder cancer Multiple myeloma Kidney cancer Ovarian cancer Pancreatic cancer Esophageal cancer Hepatocellular carcinoma These results suggest that GLP-1 receptor agonists can protect against cancer